Slide 1

News & Events

SAVE THE DATE!

It is our pleasure to announce that the 14th International VPM Days will take place on Thursday and Friday, 28 and 29 September 2023 at TWINCORE in Hannover, Germany.

READ MORE

NEWS

VPM oversees clinical trial and translational project management – Positive Phase I data of client Memo Therapeutics AG

We are pleased to announce the successful completion of a clinical client project for Memo Therapeutics AG (MTx), Switzerland. The project included a Phase I clinical trial with AntiBKV, an antibody targeting BK polyomavirus (BKV) infection in renal transplant patients. VPM oversaw the clinical trial and performed translational project management, whereas the Australian cooperation partner and contract research organization (CRO) Accelagen managed the trial, yielding positive results, with all endpoints met.

rEGISTER HERE >
READ MORE
Slide 2

NEWS

VPM oversees clinical trial and translational project management – Positive Phase I data of client Memo Therapeutics AG

Press

Results of SAKK 06/14 trial with VPM1002BC

The phase I/II clinical trial data with VPM1002BC, a genetically modified bacillus Calmette-Guérin (BCG) strain, has been published in European Urology Oncology. Even three years after the treatment start, almost half of the patients remained recurrence-free. We thank all patients, colleagues, and collaborators for their contributions.

Read more
Slide 3

A competent partner at your side

Free first consulting session

We understand how complexe product development is, because we did it ourselves. Let us be a competent partner at your side for a secure route to a successful product.

send us an e-mail >

From Bench to Product

Consulting and services

Slide 4

A competent partner at your side

Free first consulting session

From Bench to Product

Consulting and services

Speed up your development processes by using our expertise. We offer a comprehensive service portfolio covering all stages of pharmaceutical development.

Our services >
previous arrowprevious arrow
next arrownext arrow

About Vakzine Projekt Management

VPM offers tailor-made consultancy and services based on in-depth experience in development of biopharmaceutical candidates. As a client, you will benefit from the experience of our team in translational project management. This enables you to bring your development projects into clinical trials faster, more cost-effectively and with a higher probability of success.

The company was established in 2002. Within the last decade, VPM has successfully managed and consulted the development of promising biopharmaceutical candidates, ranging from small molecules, recombinant proteins up to gene-modified live vaccines and ATMPs. VPM brought these products for its customers in the pharmaceutical industry, academic research and small biotechnology companies, from preclinical phase through clinical phases I-III.

News & Press

VPM helps facilitate fast track designation for Memo Therapeutics AG’s AntiBKV first-in-class treatment for BK virus infection in renal transplant recipients

Press

Vakzine Projekt Management GmbH (VPM) announced today that it has supported Memo Therapeutics AG (MTx) during the process for receiving fast track designation from the U.S. Food and Drug Administration (FDA) for the novel human monoclonal antibody, AntiBKV, developed by MTx for the treatment of BK viremia in kidney transplant recipients. READ MORE

11.05.2023

Consulting and services

Speed up your development processes by using our expertise. We offer a comprehensive service portfolio covering all stages of pharmaceutical development.

Our Method

Translational project management from the laboratory bench to clinical development.